cdk4/6 inhibitors: a new class of drugs for cancer treatment
Published 1 year ago • 436 plays • Length 0:14Download video MP4
Download video MP3
Similar videos
-
1:25
cdk4/6 inhibitors | small molecules lock down cancer cells
-
0:15
pi3k inhibitors: a new frontier in cancer treatment
-
7:58
cdk 4/6 inhibitors: how are they used in metastatic breast cancer treatment?
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
2:27
understanding abemaciclib: a new cdk4/6 inhibitor
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
4:39
treatment following relapse on cdk4/6 inhibitors
-
7:40
cdk4/6 inhibitors in the first-line treatment setting
-
1:17:18
changing standards of care for use of cdk4 and 6 inhibitors in the treatment of breast cancer
-
3:38
comment: cdk4/6 inhibitors in advanced breast cancer
-
1:15
rebooting breast cancer treatments with parp inhibitors
-
3:22
impact of metastases-directed radiation therapy on cdk4/6 inhibitors treatment for mbc
-
7:23
study of ribociclib and pdr001 in hr metastatic breast cancer
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
1:41
dr. harold j. burstein on cdk4/cdk6 inhibitor abemaciclib in breast cancer
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
6:24
cdk4/6 inhibitors: can they be used for tnbc or her2 breast cancer?
-
1:11
a trial investigating cdk4/6 inhibitors for the treatment of mantle cell lymphoma
-
11:42
cdk4 6 inhibitors: changing the early breast cancer landscape